# BayFirst Financial Corp.: overview

BAFN · Nasdaq · CIK 1649739 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bafn.md) · [Financials](/companies/bafn/financials.md) · [Filings](/companies/bafn/filings.md) · [Insiders](/companies/bafn/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.18](/filings/0001649739-25-000250.md) | not reported | [(0.32)](/filings/0001649739-26-000050.md) | [(0.54)](/filings/0001649739-26-000061.md) | [(4.71)](/filings/0001649739-26-000049.md) | not reported | [(1.54)](/filings/0001649739-26-000050.md) | [(8.05)](/filings/0001649739-26-000061.md) |
| Free cash flow | $m | [90.5 d](/filings/0001649739-25-000250.md) | [100 d](/filings/0001649739-26-000049.md) | [75.0](/filings/0001649739-26-000049.md) | [64.0 d](/filings/0001649739-26-000061.md) | [48.2 d](/filings/0001649739-26-000049.md) | [101 d](/filings/0001649739-26-000049.md) | [(3.2)](/filings/0001649739-26-000028.md) | [0.3 d](/filings/0001649739-26-000061.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [5.91](/filings/0001649739-23-000111.md) | [(0.22)](/filings/0001649739-24-000122.md) | [1.12](/filings/0001649739-25-000106.md) | [2.09](/filings/0001649739-26-000049.md) | [(6.32)](/filings/0001649739-26-000049.md) |
| Free cash flow | $m | [482](/filings/0001649739-23-000111.md) | [432](/filings/0001649739-24-000122.md) | [447](/filings/0001649739-25-000106.md) | [392](/filings/0001649739-26-000049.md) | [289](/filings/0001649739-26-000049.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bafn/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $754.0k | 150,806 |  | Added +2,171 |
| [FIRST MANHATTAN CO. LLC.](/funds/728083.md) | 2026-06-30 | $664.6k | 132,926 |  | Added +5,000 |
| [BANC FUNDS CO LLC](/funds/1029311.md) | 2026-06-30 | $458.4k | 91,679 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $264.1k | 52,828 |  | Added +1,093 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $193.9k | 38,775 |  | Reduced −5,378 |
| [STIFEL FINANCIAL CORP](/funds/720672.md) | 2026-06-30 | $183.4k | 36,673 |  | Added +5,473 |
| [Modern Wealth Management, LLC](/funds/2001900.md) | 2026-06-30 | $138.3k | 27,661 |  | New +27,661 |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $111.1k | 22,215 |  | Added +1,049 |
| [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $96.6k | 19,321 |  | Added +6,500 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $78.0k | 15,600 |  | New +15,600 |

## Recent filings

[All 791 filings](/companies/bafn/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 09:32 ET | [SCHEDULE 13D/A](/filings/0001649739-26-000139.md) | Ownership report, active investor, amended | 0001649739-26-000139 |
| 2026-10-13 | 16:26 ET | [SCHEDULE 13D/A](/filings/0001649739-26-000137.md) | Ownership report, active investor, amended | 0001649739-26-000137 |
| 2026-09-30 | 09:00 ET | [8-K](/filings/0001649739-26-000118.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001649739-26-000118 |
| 2026-09-29 | 12:17 ET | [8-K](/filings/0001649739-26-000114.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001649739-26-000114 |
| 2026-09-24 | 09:32 ET | [8-K](/filings/0001649739-26-000104.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001649739-26-000104 |
| 2026-09-01 | 09:06 ET | [8-K](/filings/0001649739-26-000097.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001649739-26-000097 |
| 2026-08-27 | 16:00 ET | [8-K](/filings/0001649739-26-000091.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001649739-26-000091 |
| 2026-08-21 | 15:31 ET | [S-1/A](/filings/0001649739-26-000083.md) | Registration statement, amended | 0001649739-26-000083 |
| 2026-08-21 | 15:30 ET | [S-1/A](/filings/0001649739-26-000082.md) | Registration statement, amended | 0001649739-26-000082 |
| 2026-08-20 | 16:31 ET | [S-1/A](/filings/0001649739-26-000075.md) | Registration statement, amended | 0001649739-26-000075 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001649739-26-000014.md), filed Mar 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1649739
- Tickers: BAFN
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: FL
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:01 ET. No prices; not investment advice.
